Streetbeat News

Stock Prices

PLTR

Palantir Technologies Inc (NYSE:PLTR) has seen a 400% increase in its stock price since December 2022, recently surpassing the $30 mark, which could signal further gains. The stock's ability to maintain this level is crucial for future growth.

Portfolio Pulse from Zaheer Anwari

August 19, 2024 | 4:09 pm

FTXH

IBBQ

IDNA

LGHT

MRNA

NVAX

PFE

The FDA is expected to approve updated COVID-19 vaccines from Moderna, Pfizer, and possibly Novovax this week. This approval is in response to a significant summer outbreak in the U.S. Moderna and Pfizer have vaccines ready for distribution, while Novovax's vaccine will be available later this month. Stocks of these companies and related ETFs have shown gains in anticipation of the approval.

Portfolio Pulse from Michael Juliano

August 19, 2024 | 4:08 pm

CNC

Over the past three months, 17 analysts have provided ratings for Centene (NYSE:CNC), with a mix of bullish and bearish sentiments. The average 12-month price target has decreased by 3.11% to $86.47. Analysts have adjusted their ratings and price targets in response to market dynamics and company performance. Centene, a managed-care organization, has shown revenue growth but faces challenges with net margin and debt management.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 4:01 pm

RGLD

Analysts have mixed ratings for Royal Gold (NASDAQ:RGLD) with recent upgrades in price targets. The average 12-month price target increased by 3.8% to $156.0. Royal Gold shows strong financial performance with high net margins and low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 4:00 pm

ELV

Analysts have provided a range of ratings for Elevance Health (NYSE:ELV) over the past three months, with most being somewhat bullish. The average 12-month price target is $607.47, slightly down from previous estimates. Despite a slight revenue decline, Elevance Health shows strong financial performance with high net margins and ROE. However, it faces challenges in debt management.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 4:00 pm

NKE

Deep-pocketed investors are showing a bullish interest in Nike (NKE) through significant options activity, with a focus on a price range of $40 to $105. Analysts have mixed ratings, with a recent upgrade to 'Buy' and a target price of $93.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 4:00 pm

CSCO

Recent options trading trends indicate a bearish sentiment among big-money investors towards Cisco Systems (NASDAQ:CSCO), with 50% of trades being bearish. The options activity suggests a focus on a price range between $45.0 and $52.5. Despite this, some analysts maintain a positive outlook with price targets up to $58.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 4:00 pm

FCX

Analysts have mixed ratings for Freeport-McMoRan (NYSE:FCX), with a recent average price target of $57.5, up from $55.75. The company shows strong revenue growth but faces challenges in profitability and debt management.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 4:00 pm

WFC

Investors are taking a bullish stance on Wells Fargo (NYSE:WFC) as significant options trades have been spotted, with 72% of the sentiment being bullish. The options activity suggests a focus on a price range between $40.0 and $60.0. The stock is currently trading at $56.12, up 1.42%, with a neutral RSI. An analyst from Morgan Stanley maintains an Overweight rating with a target price of $68.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 4:00 pm

IDXX

IDEXX Laboratories (NASDAQ:IDXX) has significantly outperformed the market over the past 20 years, with an annualized return of 12.27%. A $100 investment in IDXX 20 years ago would now be worth $987.53, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 4:00 pm